ecrin-mdr-crcClinical2020IPD Sharing (as of February 2023): UndecidedColorectal NeoplasmsColorectal Cancer MetastaticColorectal NeoplasmsColorectal Cancer MetastaticInterventionalhttps://newmdr.ecrin.org/Study/2370127China7VemurafenibCamptothecinIrinotecanCetuximabECRIN MDRCompletedfalseEfficacy of VIC Regimen in BRAF Mutant Metastatic Colorectal CancerThis prospective, multicenter, single arm clinical trial was designed to evaluate the efficacy and safety of Vemurafenib in combination with Irinotecan and Cetuximab in the treatment of BRAF V600E-Mutant Metastatic Colorectal Cancer.2020-07-152370127NCT04790448